Katherine Crew

Associate Professor

Columbia University Irving Medical Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Katherine Crew is an Associate Professor at Columbia University Medical Center in the United States. Her research focuses on breast cancer care and includes studies on drug interactions, patient adherence to treatment, and the impact of racial discrimination in healthcare. Recent articles highlight her work on decision support tools and comparative risk assessments in breast cancer patients.

Articles (13)

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (5)

Meghna Trivedi

Assistant Professor

Columbia University Irving Medical Center

UNITED STATES

View details

Stacy Gray

Associate Clinical Professor

City of Hope

UNITED STATES

View details

Kevin Kalinsky

Emory University

UNITED STATES

View details

Melissa P. Beauchemin

Columbia University Irving Medical Center

UNITED STATES

View details

Joshua Roth

Affiliate Assistant Professor

University of Washington

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Katherine Crew

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Pharmacist-Led Video Consultation to Identify and Mitigate Drug Interactions Among Patients Initiating Oral Anticancer Drugs

Use of a Smartphone Application to Promote Adherence to Oral Medications in Patients With Breast Cancer

Racial discrimination among women seeking breast cancer care

Breast Cancer Risk and Screening Mammography Frequency Among Multiethnic Women

Comparing Breast Cancer and Cardiovascular Disease Risk and Use of Chemoprevention and Statins among Women with High-risk Breast Lesions

Patient and Provider Web-Based Decision Support for Breast Cancer Chemoprevention: A Randomized Controlled Trial

Patient Knowledge and Expectations About Return of Genomic Results in a Biomarker-Driven Master Protocol Trial (SWOG S1400GEN)

Changes in Diffuse Optical Tomography Images During Early Stages of Neoadjuvant Chemotherapy Correlate with Tumor Response in Different Breast Cancer Subtypes

Predictors of Pain Reduction in Trials of Interventions for Aromatase Inhibitor–Associated Musculoskeletal Symptoms

Perceptions of Racially and Ethnically Diverse Women at High Risk of Breast Cancer Regarding the Use of a Web-Based Decision Aid for Chemoprevention: Qualitative Study Nested Within a Randomized Controlled Trial

Better Together: Clinical and Genomic Data to Inform Shared Decision Making

Prospective Study Evaluating Changes in Bone Quality in Premenopausal Women With Breast Cancer Undergoing Adjuvant Chemotherapy

Phase 1 Study of Erlotinib and Metformin in Metastatic Triple-Negative Breast Cancer

Collaborators (5)

Meghna Trivedi

Stacy Gray

Kevin Kalinsky

Melissa P. Beauchemin

Joshua Roth

Make your next move.